{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:55:17Z","timestamp":1781787317805,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.biopha.2020.111166","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T05:56:53Z","timestamp":1608962213000},"page":"111166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Yishen-tongbi decoction inhibits excessive activation of B cells by activating the Fc\u03b3RIIb\/Lyn\/SHP-1 pathway and attenuates the inflammatory response in CIA rats"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-6998","authenticated-orcid":false,"given":"Congqi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanqin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3072-9084","authenticated-orcid":false,"given":"Lianyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.111166_bib0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.111166_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.biopha.2020.111166_bib0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00296-010-1370-0","article-title":"Traditional Chinese medicine in the treatment of rheumatoid arthritis: a general review","volume":"30","author":"Zhang","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2020.111166_bib0020","first-page":"413","article-title":"Study on the mechanism of ethyl acetate part of Tongbi mixture regulating cellular immunity in CIA rats","volume":"23","author":"Chen","year":"2012","journal-title":"New Chin. Med. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111166_bib0025","series-title":"Clinical Research of Jiawei-Tongbi Decotion on Treatment of Rheumatoid Arthritis [Dissertation\/Master\u2019s Thesis]","author":"Tan","year":"2010"},{"key":"10.1016\/j.biopha.2020.111166_bib0030","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biopha.2020.111166_bib0035","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2020.111166_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13075-016-0951-z","article-title":"Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration","volume":"18","author":"Chatzidionysiou","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2020.111166_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2020.111166_bib0050","first-page":"1697","article-title":"Effect of down-regulation of Fc\u03b3RIIb in the activation of B cells in kidney deficiency syndrome in rheumatoid arthritis","volume":"25","author":"Liu","year":"2019","journal-title":"Chin. J. Basic Med. TCM"},{"key":"10.1016\/j.biopha.2020.111166_bib0055","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1002\/art.11313","article-title":"A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling","volume":"48","author":"Li","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2020.111166_bib0060","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1002\/art.22275","article-title":"The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis","volume":"54","author":"Radstake","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2020.111166_bib0065","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1288","article-title":"Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts","volume":"11","author":"Floto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.111166_bib0070","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/hmg\/ddi320","article-title":"FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling","volume":"14","author":"Kono","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2020.111166_bib0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imlet.2014.08.016","article-title":"Dysregulated Fc receptor function in active rheumatoid arthritis","volume":"162","author":"Magnusson","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2020.111166_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/intimm\/10.2.141","article-title":"Fc gammaRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells","volume":"10","author":"Koncz","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2008.03594.x","article-title":"Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats","volume":"152","author":"Nielsen","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0090","article-title":"Joint imaging characteristics of collagen-induced arthritis in rats","volume":"4","author":"Chen","year":"2008","journal-title":"Chin. J. Exp. Anim."},{"key":"10.1016\/j.biopha.2020.111166_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1074-7613(00)80509-9","article-title":"Fc gammaRIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation","volume":"7","author":"Hippen","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2020.111166_bib0100","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4049\/jimmunol.1301361","article-title":"CD19 and CD32b differentially regulate human B cell responsiveness","volume":"192","author":"Karnell","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jcsm.12280","article-title":"Collagen-induced arthritis as an animal model of rheumatoid cachexia","volume":"9","author":"Alabarse","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2020.111166_bib0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2016.04.031","article-title":"Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats","volume":"187","author":"Wang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.111166_bib0115","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/art.27477","article-title":"Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold","volume":"62","author":"Veri","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2020.111166_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ni.1794","article-title":"Checkpoints in lymphocyte development and autoimmune disease","volume":"11","author":"von Boehmer","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2017.1280030","article-title":"B cells and autoimmunity 2016","volume":"50","author":"Zouali","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biopha.2020.111166_bib0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/imr.12368","article-title":"FcgammaRIIB and autoimmunity","volume":"269","author":"Espeli","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2020.111166_bib0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/187152612800564455","article-title":"Role of inhibitory BCR co-receptors in immunity","volume":"12","author":"Tsubata","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2020.111166_bib0140","doi-asserted-by":"crossref","first-page":"18772","DOI":"10.1073\/pnas.1111810108","article-title":"Fcgamma receptor IIB (FcgammaRIIB) maintains humoral tolerance in the human immune system in vivo","volume":"108","author":"Baerenwaldt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.111166_bib0145","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.10257","article-title":"Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility","volume":"46","author":"Kyogoku","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2020.111166_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05132.x","article-title":"FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus","volume":"1183","author":"Niederer","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2020.111166_bib0155","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1073\/pnas.0915133107","article-title":"A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus","volume":"107","author":"Willcocks","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.111166_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ni1151","article-title":"The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells","volume":"6","author":"Fukuyama","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","article-title":"Early events in B cell activation","volume":"28","author":"Harwood","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.021908.132541","article-title":"B cell signaling and fate decision","volume":"28","author":"Kurosaki","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-2478(03)00078-6","article-title":"Feedback regulation by IgG antibodies","volume":"88","author":"Heyman","year":"2003","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2020.111166_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0190","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.4049\/jimmunol.165.8.4453","article-title":"Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling","volume":"165","author":"Fong","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.111166_bib0195","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.4049\/jimmunol.1400101","article-title":"Through an ITIM-independent mechanism the FcgammaRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19","volume":"192","author":"Xu","year":"2014","journal-title":"J. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220313597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220313597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:07:34Z","timestamp":1760098054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220313597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":39,"alternative-id":["S0753332220313597"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111166","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yishen-tongbi decoction inhibits excessive activation of B cells by activating the Fc\u03b3RIIb\/Lyn\/SHP-1 pathway and attenuates the inflammatory response in CIA rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111166"}}